| P2093 | author name string | Alfred M Del Vecchio | |
| | Changbao Liu | |
| | Lester L Gutshall | |
| | Nicole D Day | |
| | Patrick J Branigan | |
| | Robert T Sarisky | |
| | José A Melero | |
| | Jianquan Luo | |
| P2860 | cites work | Use of a novel cell-based fusion reporter assay to explore the host range of human respiratory syncytial virus F protein | Q24815873 |
| | Structural characterization of the human respiratory syncytial virus fusion protein core | Q27628799 |
| | The structure of the fusion glycoprotein of Newcastle disease virus suggests a novel paradigm for the molecular mechanism of membrane fusion | Q27631011 |
| | The structural biology of type I viral membrane fusion | Q28188215 |
| | Mortality associated with influenza and respiratory syncytial virus in the United States | Q29615578 |
| | Viral infections in immunocompromised patients: what's new with respiratory viruses? | Q30309653 |
| | Characterization of two antigenic sites recognized by neutralizing monoclonal antibodies directed against the fusion glycoprotein of human respiratory syncytial virus | Q30334543 |
| | Isolation of a second recombinant human respiratory syncytial virus monoclonal antibody fragment (Fab RSVF2-5) that exhibits therapeutic efficacy in vivo | Q32071192 |
| | Recombinant respiratory syncytial virus bearing a deletion of either the NS2 or SH gene is attenuated in chimpanzees. | Q33645414 |
| | Production of infectious human respiratory syncytial virus from cloned cDNA confirms an essential role for the transcription elongation factor from the 5' proximal open reading frame of the M2 mRNA in gene expression and provides a capability for va | Q33707803 |
| | Respiratory syncytial virus (RSV) SH and G proteins are not essential for viral replication in vitro: clinical evaluation and molecular characterization of a cold-passaged, attenuated RSV subgroup B mutant | Q33738521 |
| | Fatty acid acylation of the fusion glycoprotein of human respiratory syncytial virus | Q45843467 |
| | Post-translational Processing and Oligomerization of the Fusion Glycoprotein of Human Respiratory Syncytial Virus | Q45857342 |
| | Protective epitopes on the fusion protein of respiratory syncytial virus recognized by murine and bovine monoclonal antibodies | Q45872477 |
| | Intracellular processing of the human respiratory syncytial virus fusion glycoprotein: amino acid substitutions affecting folding, transport and cleavage | Q45873290 |
| | Identification of the respiratory syncytial virus proteins required for formation and passage of helper-dependent infectious particles. | Q33785124 |
| | Structure of the uncleaved ectodomain of the paramyxovirus (hPIV3) fusion protein | Q33855371 |
| | Cleavage of the human respiratory syncytial virus fusion protein at two distinct sites is required for activation of membrane fusion | Q33934074 |
| | Respiratory syncytial virus infections in immunocompromised adults | Q34004104 |
| | Analysis of the genomic sequence of a human metapneumovirus | Q34130526 |
| | Inhibition of Respiratory Syncytial Virus Fusion by the Small Molecule VP-14637 via Specific Interactions with F Protein | Q34975477 |
| | Disulfide bonds as switches for protein function | Q35114294 |
| | Orally active fusion inhibitor of respiratory syncytial virus | Q35547902 |
| | Respiratory syncytial virus fusion glycoprotein: nucleotide sequence of mRNA, identification of cleavage activation site and amino acid sequence of N-terminus of F1 subunit | Q36137180 |
| | Recombinant respiratory syncytial virus from which the entire SH gene has been deleted grows efficiently in cell culture and exhibits site-specific attenuation in the respiratory tract of the mouse | Q36548529 |
| | Marked differences in the antigenic structure of human respiratory syncytial virus F and G glycoproteins | Q36780922 |
| | Cysteine mutants of herpes simplex virus type 1 glycoprotein D exhibit temperature-sensitive properties in structure and function. | Q36793428 |
| | Conformational studies of a short linear peptide corresponding to a major conserved neutralizing epitope of human respiratory syncytial virus fusion glycoprotein | Q36823304 |
| | Temperature-sensitive Mutants of Respiratory Syncytial Virus | Q37133871 |
| | RFI-641 inhibits entry of respiratory syncytial virus via interactions with fusion protein | Q39416825 |
| | The core of the respiratory syncytial virus fusion protein is a trimeric coiled coil | Q39591661 |
| | N-glycans of F protein differentially affect fusion activity of human respiratory syncytial virus | Q39602758 |
| | Functional analysis of recombinant respiratory syncytial virus deletion mutants lacking the small hydrophobic and/or attachment glycoprotein gene | Q39603697 |
| | Assignment of disulfide bridges in the fusion glycoprotein of Sendai virus. | Q40040650 |
| | Two disulfide-linked polypeptide chains constitute the active F protein of paramyxoviruses | Q40081618 |
| | Monoclonal antibodies to respiratory syncytial virus proteins: identification of the fusion protein | Q40137560 |
| | The cytoplasmic domain of the F protein of Human respiratory syncytial virus is not required for cell fusion | Q40326023 |
| | Protein-disulfide isomerase-mediated reduction of two disulfide bonds of HIV envelope glycoprotein 120 occurs post-CXCR4 binding and is required for fusion | Q40705636 |
| | Respiratory syncytial virus with the fusion protein as its only viral glycoprotein is less dependent on cellular glycosaminoglycans for attachment than complete virus | Q40732224 |
| | Contribution of the respiratory syncytial virus G glycoprotein and its secreted and membrane-bound forms to virus replication in vitro and in vivo | Q40771213 |
| | Furin cleavage of the respiratory syncytial virus fusion protein is not a requirement for its transport to the surface of virus-infected cells | Q40803835 |
| | Cleavage of the respiratory syncytial virus fusion protein is required for its surface expression: role of furin | Q40863649 |
| | Recombinant respiratory syncytial viruses with deletions in the NS1, NS2, SH, and M2-2 genes are attenuated in vitro and in vivo | Q40868890 |
| | Mechanism of selective inhibition of respiratory syncytial virus by a benzodithiin compound (RD3-0028). | Q43724047 |
| | Multiple glycosylated forms of the respiratory syncytial virus fusion protein are expressed in virus-infected cells | Q43830376 |
| | Modelling the structure of the fusion protein from human respiratory syncytial virus | Q44009340 |
| | Substituted benzimidazoles with nanomolar activity against respiratory syncytial virus | Q44668921 |
| | Thermostability of the human respiratory syncytial virus fusion protein before and after activation: implications for the membrane-fusion mechanism | Q45548739 |
| | Structural characterization of respiratory syncytial virus fusion inhibitor escape mutants: homology model of the F protein and a syncytium formation assay | Q45722724 |
| | Cloning, expression, and crystallization of the fusion protein of Newcastle disease virus | Q45733423 |
| | Heptad-repeat regions of respiratory syncytial virus F1 protein form a six-membered coiled-coil complex | Q45740595 |
| | Electron microscopy of the human respiratory syncytial virus fusion protein and complexes that it forms with monoclonal antibodies | Q45742418 |
| | A direct comparison of the activities of two humanized respiratory syncytial virus monoclonal antibodies: MEDI-493 and RSHZl9. | Q45749179 |
| | Respiratory syncytial virus pneumonia among the elderly: an assessment of disease burden | Q45752482 |
| | Development of a humanized monoclonal antibody (MEDI-493) with potent in vitro and in vivo activity against respiratory syncytial virus | Q45759631 |
| | Analysis of respiratory syncytial virus F, G, and SH proteins in cell fusion | Q45778546 |
| | Isolation and characterization of a highly attenuated respiratory syncytial virus (RSV) vaccine candidate by mutagenesis of the incompletely attenuated RSV A2 ts-1 NG-1 mutant virus | Q45789084 |
| | Respiratory syncytial virus polypeptides. III. The envelope-associated proteins | Q45794076 |
| | Characterization of the 10 proteins of human respiratory syncytial virus: identification of a fourth envelope-associated protein | Q45828134 |
| | Nucleotide sequence of the gene encoding the Newcastle disease virus fusion protein and comparisons of paramyxovirus fusion protein sequences | Q45829414 |
| P921 | main subject | respiratory syncytial virus | Q1052913 |
| | RSV precursor fusion glycoprotein F0 | Q115694203 |
| P304 | page(s) | 34 | |
| P577 | publication date | 2006-05-24 | |
| P1433 | published in | Virology Journal | Q7934868 |
| P1476 | title | Contribution of cysteine residues in the extracellular domain of the F protein of human respiratory syncytial virus to its function | |
| P478 | volume | 3 | |